Drug Shortage Report for SOFRACORT

Last updated on 2024-06-07 History
Report ID 202983
Drug Identification Number 02224623
Brand name SOFRACORT
Common or Proper name Framycetin sulphate, Dexamethasone and Gramicidin Ophthalmic/Otic Solution
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH
Market Status MARKETED
Active Ingredient(s) GRAMICIDIN DEXAMETHASONE FRAMYCETIN SULFATE
Strength(s) 0.05MG 0.5MG 5MG
Dosage form(s) DROPS
Route of administration OTIC OPHTHALMIC OTIC OPHTHALMIC
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 8 mL bottle
ATC code S03CA
ATC description CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION
Reason for shortage Other (Please describe in comments)
Anticipated start date 2023-08-28
Actual start date 2023-08-28
Estimated end date
Actual end date 2024-06-06
Shortage status Resolved
Updated date 2024-06-07
Company comments Requirements related to complying with good manufacturing practices.
Health Canada comments
Tier 3 Status No
Contact Address ZIEGELHOF 24
GREIFSWALD, MECKLENBURG - WEST POMERANIA
GERMANY 17489
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-06-07 English Compare
v9 2024-06-06 French Compare
v8 2024-06-06 English Compare
v7 2023-12-01 French Compare
v6 2023-12-01 English Compare
v5 2023-10-02 French Compare
v4 2023-10-02 English Compare
v3 2023-08-29 English Compare
v2 2023-08-25 French Compare
v1 2023-08-25 English Compare

Showing 1 to 10 of 10